NCT04038502 · Interventional trial
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Overall registry status Recruiting
Phase 2
Conditions BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, Metastatic Castrate Resistant Prostate Cancer, RAD51B, RAD51C, RAD51D, or RAD54L Mutations
Delaware Valley sites
- Philadelphia MultiService Center, Philadelphia, PA · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory